[
  {
    "ts": "2026-01-19T01:10:39+00:00",
    "headline": "What Eli Lilly (LLY)'s NVIDIA AI Lab And Obesity Data Reveal About Its Obesity Leadership Narrative",
    "summary": "In recent weeks, Eli Lilly has deepened its push into AI-driven drug discovery and obesity care, including a planned US$1.00 billion co-innovation lab with NVIDIA, new AI collaborations such as Chai Discovery and TuneLab integrations, and positive Phase 3b data combining Taltz with Zepbound in psoriatic arthritis and obesity. At the same time, Strive Compounding Pharmacy’s federal antitrust lawsuit against Eli Lilly and Novo Nordisk over compounded GLP-1 access underscores growing legal and...",
    "url": "https://finance.yahoo.com/news/eli-lilly-lly-nvidia-ai-011039185.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "6981af45-3e18-3efe-938c-cd2a9438b585",
      "content": {
        "id": "6981af45-3e18-3efe-938c-cd2a9438b585",
        "contentType": "STORY",
        "title": "What Eli Lilly (LLY)'s NVIDIA AI Lab And Obesity Data Reveal About Its Obesity Leadership Narrative",
        "description": "",
        "summary": "In recent weeks, Eli Lilly has deepened its push into AI-driven drug discovery and obesity care, including a planned US$1.00 billion co-innovation lab with NVIDIA, new AI collaborations such as Chai Discovery and TuneLab integrations, and positive Phase 3b data combining Taltz with Zepbound in psoriatic arthritis and obesity. At the same time, Strive Compounding Pharmacy’s federal antitrust lawsuit against Eli Lilly and Novo Nordisk over compounded GLP-1 access underscores growing legal and...",
        "pubDate": "2026-01-19T01:10:39Z",
        "displayTime": "2026-01-19T01:10:39Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uZWvuDuy6_Wr6cKvxAFZcw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/g78F5NO5pySOmBHzFi6.eA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-nvidia-ai-011039185.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-nvidia-ai-011039185.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]